Lion Point Capital’s Seres Therapeutics MCRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$280K Hold
31,570
1.67% 26
2025
Q4
$470K Buy
31,570
+4,432
+16% +$77.3K 2.43% 17
2025
Q3
$522K Buy
27,138
+10,100
+59% +$161K 2.97% 17
2025
Q2
$189K Hold
17,038
1.29% 18
2025
Q1
$239K Hold
17,038
1.52% 18
2024
Q4
$283K Hold
17,038
1.48% 18
2024
Q3
$322K Hold
17,038
0.72% 21
2024
Q2
$247K Hold
17,038
0.45% 21
2024
Q1
$264K Hold
17,038
0.15% 25
2023
Q4
$477K Sell
17,038
-17,552
-51% -$461K 0.24% 21
2023
Q3
$1.65M Hold
34,590
0.73% 11
2023
Q2
$3.31M Buy
34,590
+4,750
+16% +$517K 1.5% 8
2023
Q1
$3.38M Hold
29,840
1.39% 11
2022
Q4
$3.11M Sell
29,840
-1,500
-5% -$201K 0.44% 21
2022
Q3
$3.23M Buy
31,340
+7,250
+30% +$743K 0.71% 27
2022
Q2
$2.66M Hold
24,090
0.3% 34
2022
Q1
$3.43M Hold
24,090
0.8% 24
2021
Q4
$4.01M Hold
24,090
1.08% 20
2021
Q3
$3.35M Buy
+24,090
New +$4.71M 0.63% 26

Other funds holding MCRB